(lp0
S"Nektar Therapeutics' stock jumps after positive results of its pain treatment drug MarketWatch - Mar 20, 2017 Shares of Nektar Therapeutics NKTR, +4.86% soared 18% toward a six-month high in premarket trade Monday, after reporting positive results of a late-stage trial of its opioid analgesic.Why Nektar Therapeutics Inc. Is Rising Today - Motley FoolNektar Therapeutics  Moves Higher on Volume Spike for March 22 - Equities.com"
p1
aS"BRIEF-Nektar Therapeutics says NKTR-181 meets primary, secondary endpoints in ... Reuters - Mar 20, 2017 March 20 Stock futures pointed to a lower opening for Canada's main stock index on Monday after financial leaders of the world's biggest economies dropped a pledge to keep global trade free and open."
p2
aS'Stocks of Nektar Therapeutics and CytomX Therapeutics Rise on FDA Trial News Yahoo Finance - Mar 21, 2017 That is exactly what happened to CytomX Therapeutics on Monday, as Bristol-Myers Squibb Company and CytomX announced their expansion of the 2014 strategic collaboration agreement.'
p3
aS"Can this company's pain-fighting drug smash America's opioid crisis? San Francisco Business Times - Mar 20, 2017 Facing skepticism, the company says its drug enters the brain slowly, so pain-drug addicts don't get the euphoric rush they seek, but patients get effective pain relief."
p4
aS'An intrinsic value calculation for Nektar Therapeutics  shows investors ... Simply Wall St - Mar 21, 2017 I am going to run you through how I calculated the intrinsic value of Nektar Therapeutics  by taking the expected future cash flows and discounted them to the value today.'
p5
aS"Nektar Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results PR Newswire  - Mar 1, 2017 SAN FRANCISCO, March 1, 2017 /PRNewswire/ -- Nektar Therapeutics  today reported its financial results for the fourth quarter and year ended December 31, 2016.Nektar Therapeutics  Loss Wider than Expected in Q4 - Yahoo FinanceHere's What's Behind Nektar Therapeutics' 20% Move Higher - Motley Fool"
p6
aS'Wall Street Cheers These Two Rising Stocks: Esperion Therapeutics Inc (ESPR ... Smarter Analyst - Mar 20, 2017 Esperion Therapeutics Inc  and Nektar Therapeutics  are skyrocketing with a fury today on back of major clinical strides forward that have investors today eagerly watching these needle-movers ascend up through the&nbsp;...After-hours buzz: ESPR, NKTR, MMSI &amp; more - CNBC12 Biggest Mid-Day Gainers For Monday - Benzinga'
p7
aS'Nektar Therapeutics  Breaks into New 52-Week High on March 20 Session Equities.com - Mar 20, 2017 Shares of Nektar Therapeutics  broke into a new 52-week high yesterday, hitting a peak of $22.32. Shares closed at $22.11 after opening at $18.78 for a move of 42.65%.'
p8
aS"Nektar Therapeutics: Touches near 11-year high Times of India - Mar 20, 2017 ... ** Drugmaker's shares up as much as 35 pct at near 11-year high of $20.91. ** Stock second-top percentage gainer on Nasdaq."
p9
aS"Why Investors remained confident on Hudson Pacific Properties, Inc. (HPP ... StockNewsJournal - Mar 20, 2017 Nektar Therapeutics , maintained return on investment for the last twelve months at -32.87, higher than what Reuters data shows regarding industry's average."
p10
a.